Robotic-assisted surgery for the treatment of urologic cancers: recent advances.
Gabriele Bignante, Angelo Orsini, Francesco Lasorsa, Luca Lambertini, Matteo Pacini, Daniele Amparore, Savio Domenico Pandolfo, Francesco Del Giudice, Osama Zaytoun, Maurizio Buscarini, Giuseppe Lucarelli, Luigi Schips, Alessandro Veccia, Alessandro Antonelli, Cristian Fiori, Francesco Porpiglia, Riccardo Autorino
Author Information
Gabriele Bignante: Department of Urology, Rush University Medical Center, Chicago, IL, USA. ORCID
Angelo Orsini: Department of Urology, Rush University Medical Center, Chicago, IL, USA.
Francesco Lasorsa: Department of Urology, Rush University Medical Center, Chicago, IL, USA.
Luca Lambertini: Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
Matteo Pacini: Urology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Daniele Amparore: Division of Urology, Department of Oncology, University of Turin, Orbassano, Turin, Italy.
Savio Domenico Pandolfo: Department of Urology, University of L'Aquila, L'Aquila, Italy.
Francesco Del Giudice: Department of Maternal Infant and Urologic Sciences, University of Rome La Sapienza, Rome, Lazio, Italy.
Osama Zaytoun: Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Maurizio Buscarini: Department of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Giuseppe Lucarelli: Department of Precision and Regenerative Medicine and Ionian Area-Urology, Andrology and Kidney Transplantation Unit, University of Bari "Aldo Moro", Bari, Italy.
Luigi Schips: Urology Unit, Department of Medical, Oral and Biotechnological Sciences, "G. D'Annunzio" University, Chieti, Italy.
Alessandro Veccia: Department of Urology, University of Verona, Verona, Italy.
Alessandro Antonelli: Department of Urology, University of Verona, Verona, Italy.
Cristian Fiori: Division of Urology, Department of Oncology, University of Turin, Orbassano, Turin, Italy.
Francesco Porpiglia: Division of Urology, Department of Oncology, University of Turin, Orbassano, Turin, Italy.
Riccardo Autorino: Department of Urology, Rush University Medical Center, Chicago, IL, USA.
INTRODUCTION: Recent advancements in single-port surgery, robotic platforms, 3D models and artificial intelligence have transformed surgical procedures, especially in urology. These innovations enhance precision, safety, and efficacy, reducing invasiveness and recovery times. The review focuses on the latest in robotic-assisted surgery for genitourinary cancers, highlighting the shift toward personalized, minimally invasive treatments. AREAS COVERED: A bibliographic search across PubMed, Scopus, and EMBASE databases focused on the last four years of innovations in robotic surgery for urologic tumors. The review highlights the use of the Da Vinci Single Port robotic system, available robotic platforms worldwide, advancements in 3D virtual models, artificial intelligence in robotic surgery and the application of molecular imaging for assessing primary lymph nodes and treating lymph node metastases and local recurrences in prostate cancer. EXPERT OPINION: The integration of single-port surgery, new robotic platforms, 3D models and artificial intelligence in urological oncology promises transformative impacts on diagnosis, treatment and cost-effectiveness. Despite benefits like enhanced precision and expanded surgical access, challenges such as high costs, training needs, and technological integration barriers persist. Collaboration and further research are critical to optimize outcomes, improve safety protocols, and ensure equitable global access to these innovations.
